All we need now is for some positive CDH17 results to be released.
As Bec hinted, that could trigger a major deal, that would more than likely cover costs for remaining test phases.
With the current and recent capital raises, along with the associated options - at a very low strike price -, we should be good for cash for some time. Issue is we can forget about a double figure SP for a very long time.
Bring it on, Dr. Bec!
Add to My Watchlist
What is My Watchlist?
